发明名称 Tri-substituted heteroaryls and methods of making and using the same
摘要 Disclosed is a compound of formula (I) or an N-oxide or pharmaceutical acceptable salt thereof wherein R1 is aryl, heteroaryl, aralkyl or heteroaralkyl; X is piperidinyl, piperazinyl, pyrrolidinyl, tetrahydrofuran, cyclohexyl, cyclopentyl, bicyclo[2.2.1]heptane, bicyclo[2.2.2]octane, bicyclo[3.2.1]octane, 2-oxa-bicyclo[2.2.2]octane, 2-aza- bicyclo[2.2.2]octane, 3-aza- bicyclo[3.2.1]octane or 1-aza-bicyclo[2.2.2]octane; Each of A1 and A2 are independently O, S, N or NRb provided that at least one of A1 and A2 is N; and the remainder of the substituents are as described in the specification. The compounds described are antagonists of the TGF beta type I receptors Alk5 and Alk4 useful in the treatment of disorder related to the TGF beta signalling pathway.
申请公布号 NZ536202(A) 申请公布日期 2009.08.28
申请号 NZ20030536202 申请日期 2003.04.04
申请人 BIOGEN IDEC MA INC. 发明人 LEE, WEN-CHERNG;SUN, LIHONG;CHUAQUI, CLAUDIO;ZHENG, ZHONGLI;PETTER, RUSSELL C;SHAN, FENG
分类号 A61K31/36;A61K31/395;A61K31/41;A61K31/435;A61K31/4439;A61K31/4545;A61K31/517;A61P1/16;A61P9/00;A61P11/00;A61P13/12;A61P17/00;A61P21/00;A61P27/02;A61P35/00;A61P35/04;A61P43/00;C07D401/04;C07D401/14;C07D405/04;C07D405/14;C07D409/04;C07D409/14;C07D453/00;C07D471/04;C07D487/08;C07D519/00 主分类号 A61K31/36
代理机构 代理人
主权项
地址